The Drug Discovery Technologies Market Report provides a quantitative analysis of the current market and estimations through 2014-2020

Portland, OR -- (SBWire) -- 08/09/2017 --Drug discovery is the process by which new medications are discovered. It uses vast array of technologies in the process. Drug discovery technologies are used for the research and the launch of new drugs. Increased use of therapeutics in various diseases has created the need for drug discovery. Recently, with the development of technology, many new types of techniques such as nanotechnology and RNA interference are being used for the purpose of drug discovery. This has created the opportunities for drug discovery technology manufacturers in the new segments. The increasing incidences of diseases, patent expiries, pathogen resistance to old drugs and fierce competition among drug manufacturers are the key factors, which would drive the growth of drug discovery technologies market during the analysis period. Furthermore, in order to earn additional margins, the pharmaceutical companies are in pursuit of blockbuster drugs, which has increased the demand for drug discovery technologies. Factors restraining the market growth are long duration of drug discovery process, high initial setup cost and presence of stringent regulatory environment.

Get a Sample Copy of this report: https://www.alliedmarketresearch.com/request-toc-and-sample/1480

The global drug discovery market is segmented on the basis of technology type, application and geography. The technology types considered in this report are high throughput screening, genomics, biochips, pharmacogenomics, bioanalytical instruments, bioinformatics, nanotechnology and others (RNAi, combinatorial chemistry). Based on end user, the global drug discovery market is classified into pharmaceutical companies, biopharmaceutical companies, biotech companies and research institutes. Geographically, the report is segmented into four regions viz., North America, Europe, Asia-Pacific and LAMEA. One of the strategies adopted by major market players is collaboration. For instance, in 2015, Myriad Genetics collaborated with Abbott Laboratories. The companies profiled in this report are Abbott Laboratories, Albany Molecular Research, Arqule, Bio-Rad Laboratories, Caliper Life Sciences, Celera Corp, Charles River Laboratories International, Evotec Ag, Gyros AbIncyte Corp and Thermo Fisher Scientific Inc.

The global drug discovery technologies market is segmented as below:

Global Drug Discovery Technologies Market By Technology Type

High throughput screening
Genomics
Biochips
Pharmacogenomics
Bioanalytical instruments
Bioinformatics
Nanotechnology
Others (RNAi, combinatorial chemistry)

Global Drug Discovery Technologies Market By End User

Pharmaceutical companies
Biopharmaceutical companies
Biotech companies
Research institutes

Global Drug Discovery Technologies Market By Geography

North America
Europe
Asia-Pacific
LAMEA